Home Newsfeeds Morgan Stanley Maintains Equal-Weight on Equifax, Lowers Price Target to $192

Morgan Stanley Maintains Equal-Weight on Equifax, Lowers Price Target to $192

Morgan Stanley analyst Toni Kaplan maintains Equifax (NYSE:EFX) with a Equal-Weight and lowers the price target from $212 to $192.

byBenzinga Newsdesk

October 21, 2022

1 minute read

Morgan Stanley analyst Toni Kaplan maintains Equifax (NYSE:EFX) with a Equal-Weight and lowers the price target from $212 to $192.

Pharming Provides Update On European Medicines Agency Regulatory Review Of Leniolisib For APDS In Europe; Decided To Shift Its Assessment Of The Marketing Authorisation Application For Leniolisib To A Standard Review Timetable

By Happy Mohamed

February 16, 2:11 AM

EMA Marketing Authorisation Application for leniolisib changed to standard review timetable LEIDEN, Netherlands, Feb. 16, 2023 /PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the

PHAR

CVR Energy Q3 Adj. EPS $1.90 Misses $1.93 Estimate, Sales $2.70B Beat $2.42B Estimate

By Michael Horton

Today, 5:52 PM

CVR Energy (NYSE:CVI) reported quarterly earnings of $1.90 per share which missed the analyst consensus estimate of $1.93 by 1.55 percent. This is a 891.67 percent increase over losses of $(0.24) per share from the same

CVI

Movers
News

Ford Stock Is Putting The Pedal To The Floor Wednesday: What’s Going On?

By Adam Eckert

February 7, 10:36 AM

ord's fourth-quarter revenue increased 4% year-over-year to $46 billion, which beat the consensus estimate of $39.53 billion, according to Benzinga Pro. The company reported quarterly earnings of 29 cents per share, which beat estimates of 13 cents per share.

Global
News

Yotta Data Services Collaborates With NVIDIA To Catalyze India’s AI Transformation

By Benzinga Newsdesk

December 5, 10:06 AM

Yotta launches Shakti Cloud: India's Largest Supercomputer of 16 Exaflops AI computing power with NVIDIA H100 Tensor Core GPUs to drive mass-scale AI innovation in IndiaMUMBAI, India, Dec. 5, 2023 /PRNewswire/ -- Yotta

INDA

Morgan Stanley Maintains Equal-Weight on Equifax, Lowers Price Target to $192

Related Posts

Pharming Provides Update On European Medicines Agency Regulatory Review Of Leniolisib For APDS In Europe; Decided To Shift Its Assessment Of The Marketing Authorisation Application For Leniolisib To A Standard Review Timetable

CVR Energy Q3 Adj. EPS $1.90 Misses $1.93 Estimate, Sales $2.70B Beat $2.42B Estimate

Ford Stock Is Putting The Pedal To The Floor Wednesday: What’s Going On?

Yotta Data Services Collaborates With NVIDIA To Catalyze India’s AI Transformation